EPS1.03 Recommended shielding against COVID-19 impacts physical activity levels and adherence to airway clearance therapy in patients with cystic fibrosis

類似資料

• Toward the Establishment of New Clinical Endpoints for Cystic Fibrosis: The Role of Lung Clearance Index and Cardiopulmonary Exercise Testing
  著者:: Hatziagorou, Elpis, 等
  出版事項: (2021)
• Use of lung clearance index to assess the response to intravenous treatment in cystic fibrosis
  著者:: Hatziagorou, E, 等
  出版事項: (2015)
• Home intravenous antibiotic therapy in children with cystic fibrosis: clinical outcome, quality of life and economic benefit
  著者:: Chrysochoou, EA, 等
  出版事項: (2016)
• EP03 Parechovirus in a pathologist
  著者:: Masih, Claire, 等
  出版事項: (2020)
• Assessment of airway inflammation with exhaled NO measurement
  著者:: Hatziagorou, E, 等
  出版事項: (2007)